At Praxis, we understand the urgent need for those living with Essential Tremor to have better treatment options and we are committed to continuing to develop new potential treatment options.
Praxis is excited to be investigating a new potential treatment called ulixacaltamide for adults diagnosed with essential tremor.
If you would like to learn more and see if you may qualify, please visit the study website and complete the online pre-screening assessment.
If you pre-qualify, a study staff member will contact you to discuss additional details about participating.
